Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cyclosporin in atopic dermatitis].

M L Pacor1, D Biasi, G Di Lorenzo

  • 1Cattedra di Allergologia e Immunologia Clinica, Università, Verona.

Recenti Progressi in Medicina
|July 4, 2001
PubMed
Summary

Cyclosporin A effectively treats atopic dermatitis, significantly improving skin lesions, itch, and sleep in non-responsive patients. This oral treatment showed no significant side effects or relapses over a six-month follow-up.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resting-state functional connectivity and cognitive impairment after COVID-19 infection: Evidence from a large-scale fMRI study.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Clinical terminology and biological mediators in allergology: why biomarkers do not define a syndrome.

European annals of allergy and clinical immunology·2026
Same author

READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinoma.

ESMO real world data and digital oncology·2026
Same author

Investigating the impact of the regularization parameter on EEG resting-state source reconstruction and functional connectivity using real and simulated data.

NeuroImage·2024
Same author

Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis.

Reumatismo·2024
Same author

Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement.

Reumatismo·2023

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Atopic dermatitis is a chronic inflammatory skin condition.
  • Existing treatments are often insufficient for severe cases.
  • Cyclosporin A is an immunosuppressant with potential therapeutic benefits.

Purpose of the Study:

  • To evaluate the efficacy and safety of oral Cyclosporin A in patients with atopic dermatitis.
  • To assess the impact of Cyclosporin A on key disease symptoms and patient-reported outcomes.

Main Methods:

  • An open, prospective study involving 15 adult patients with atopic dermatitis.
  • Oral administration of Cyclosporin A at 5 mg/kg/day for 8 weeks.
  • Patient diaries recorded skin lesion extension, itch, and sleep disturbance severity (0-3 scale).

Main Results:

  • Significant improvement in evaluated symptoms including skin lesions, itch, and sleep quality.
  • No significant adverse events were reported during the treatment or follow-up period.
  • No disease relapses were observed during the 6-month post-treatment follow-up.

Conclusions:

  • Oral Cyclosporin A is a safe and effective treatment option for patients with atopic dermatitis refractory to other therapies.
  • The observed improvements were sustained post-treatment, suggesting a lasting therapeutic effect.
  • Further research may explore long-term efficacy and optimal dosing strategies.

Related Experiment Videos